Short-term observation on clinical efficacy of treating acute cerebral infarction by Edaravone combined with Clopidogrel
10.3760/cma.j.issn.1674-6090.2015.01.012
- VernacularTitle:依达拉奉联合氯吡格雷治疗急性脑梗死近期临床疗效观察
- Author:
Jianhua ZHANG
;
Wenbin CHEN
- Publication Type:Journal Article
- Keywords:
Aacute cerebral infarction;
Edaravone;
Clopidogrel;
Free radical;
Platelet
- From:
Journal of Endocrine Surgery
2015;9(1):38-40,55
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the short-term efficacy and safety of edaravone combined with clopidogrel in treatment of acute cerebral infarction (ACI).Methods 120 cases of ACI were selected and they were randomly divided into the observation group(60 cases)and the control group according to the visiting order(60 cases).On the basis of routine treatment of ACI,the control group were treated with clopidogrel,and the observation group were added with edaravone combined with clopidogrel.All patients were treated continuously for 14 days.Patients' neural function,activities of daily living,and adverse reactions were evaluated before and after treatment.All patients were followed up for 1 year to record recurrence.Results After treatment,patients' limb movements,neural functions and language had varying degrees of recovery.Total efficiency was 93.33％ and 78.33％ respectively for the observation group and the control group.Grading of the neurologic impairment and life ability of the observation group were both better than the control group.The one-year recurrence rate was 5.77 ％ and 9.26％ for the observation group and the control group,and the difference had statistical significance (P ＜ 0.05).No obvious adverse reaction in the 2 groups was found.Conclusion The curative effect of edaravone combined with clopidogrel is remarkable in treating ACI,and it can remit patients' neurological deficit,improve their daily life ability,reduce the recurrence rate,and has high safety.
